Enzalutamide CAS 915087-33-1 99% Purity Androgen Receptor Antagonist API Intermediate for Prostate Cancer Research fk
TDS 6 Inquiries
915087-33-1
Reagent Grade
99%
qingdao
//
10mg, 25mg, 50mg, 100mg, 1g
Yes
2026-10-26
Medetomidine,Medetomidine hydrochloride,D-Lysergic Acid Methyl Ester,SR17018,Fluralaner,GS-441524
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceEnzalutamide (MDV3100) is an androgen receptor (AR) antagonist with an IC50 of 36 nM in LNCaP prostate cells.
Enzalutamide is a benzamide obtained by formal condensation of the carboxy group of 4-{3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl}-2-fluorobenzoic acid with methylamine. Used for the treatment of of metastatic castration-resistant prostate cancer. It has a role as an antineoplastic agent and an androgen antagonist. It is a member of benzamides, an imidazolidinone, a thiocarbonyl compound, a nitrile, a member of (trifluoromethyl)benzenes and a member of monofluorobenzenes.|Enzalutamide is an androgen receptor inhibitor for the treatment of castration-resistant prostate cancer. FDA approved on August 31, 2012.|Enzalutamide is an Androgen Receptor Inhibitor. The mechanism of action of enzalutamide is as an Androgen Receptor Antagonist, and Cytochrome P450 3A4 Inducer, and Cytochrome P450 2C9 Inducer, and Cytochrome P450 2C19 Inducer.|Enzalutamide is a nonsteroidal antiandrogen used to treat metastatic castration-resistant prostate cancer. Enzalutamide is associated with a low rate of serum enzyme elevation during therapy, but has not been linked to cases of clinically apparent liver injury with jaundice.|Enzalutamide is an orally bioavailable, organic, non-steroidal small molecule targeting the androgen receptor (AR) with potential antineoplastic activity. Through a mechanism that is reported to be different from other approved AR antagonists, enzalutamide inhibits the activity of prostate cancer cell ARs, which may result in a reduction in prostate cancer cell proliferation and, correspondingly, a reduction in the serum prostate specific antigen (PSA) level. AR over-expression in prostate cancer represents a key mechanism associated with prostate cancer hormone resistance.Research & Reference NoteEnzalutamide CAS 915087-33-1 99% Purity Androgen Receptor Antagonist API Intermediate for Prostate Cancer Research fk is listed on ECHEMI for industrial / laboratory sourcing. This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Authoritative sourcesDisclaimer: This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Reviewed by ECHEMI Scientific Review - Platform editorial review for research chemicals
Certificates-
TDS
Basic Info-
Product Name:
Enzalutamide
Other Name:Benzamide,4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methyl-;4-[3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methylbenzamide;MDV 3100;Enzalutamide;Xtandi;S-Enzalutamide
CAS No.:915087-33-1
Molecular Formula:C21H16F4N4O2S
InChIKeys:InChIKey=WXCXUHSOUPDCQV-UHFFFAOYSA-N
Molecular Weight:464.4359528
Exact Mass:464.44
EC Number:1592732-453-0
UNII:93T0T9GKNU
NCI Thesaurus Code:C71744
ATC Code:L02BB04|L - Antineoplastic and immunomodulating agents
HScode:2933990090
Categories:
Characteristics-
PSA:
109
XLogP3:3.6
Density:1.5±0.1 g/cm3
Refractive Index:1.630
Water Solubility:Insoluble
Hazard IdentificationClassification of the substance or mixture
Reproductive toxicity, Category 2
GHS label elements, including precautionary statements
Pictogram(s)
Signal word Warning
Hazard statement(s) H361 Suspected of damaging fertility or the unborn child
Precautionary statement(s) Prevention P203 Obtain, read and follow all safety instructions before use.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
Response P318 IF exposed or concerned, get medical advice.
Storage P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Medetomidine,Medetomidine hydrochloride,D-Lysergic Acid Methyl Ester,SR17018,Fluralaner,GS-441524
-
Location:
RONGSHENG BEIYUANDAJIE 9, LICHENG DISTRICT,JINAN, SHANDONG CHINA
-
Payment Terms:
TT against copy of documents,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
7 days
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
11-50
-
Year of Establishment:
2022
-
-
Inquiry History6 Inquiries
Country Product Purchase Quantity Date Posted
Malaysia
99% Enzalutamide
1 KG May 26, 2025
India
Enzalutamide
250.00 G May 21, 2025
United States
Enzalutamide
1 KG Feb 17, 2025
India
Enzalutamide
50 KG Oct 19, 2025
India
Enzalutamide
250 G May 21, 2025
Spain
enzalutamide
100 G Nov 18, 2024 Post an enquiry for this product
More from this Seller
-
-
-
Varenicline Tartrate CAS 375815-87-5 Nicotinic Acetylcholine Receptor Partial Agonist for Smoking Cessation Research fkhc
Reagent Grade / 99%
$100-130/G FOB
-
-
-
-
8-Hydroxydigitoxigenin 98% Purity Natural Cardiac Glycoside Aglycone Reference Standard CAS 1049674-06-7 HPLC Grade
Research Grade / 98%
$68-72/G FOB
-
-
-
-
1-(Pyrrolidin-3-yl)-1H-imidazole Hydrochloride 98% Purity Heterocyclic Building Block CAS 1263284-62-3 Pharmaceutical Intermediate
Research Grade / 98%
$68-75/G FOB
-
-
-
-
sr 15099 cas 2134602-44-9 SR-17018 Impurity 4 kr lab research use sr15099 kr
Reagent Grade / 99%
$1/G FOB
-